CognitiveCare published a new manuscript titled Prediction of retinopathy of prematurity using machine learning models in Pediatric Research.

CognitiveCare is a trailblazing force in improving healthcare outcomes. We utilize scientific rigor to unveil and address health disparities, enhance disease prevention and management, accelerate health economics outcomes research, and catalyze optimal efficacy in pharma and life sciences. With a foundation rooted in patented and proprietary risk quantification and resource allocation algorithms, we serve payers, providers, policymakers, public health departments, pharma, and life sciences clients, driving impact for both individual and population health. CongitiveCare is poised to revolutionize the healthcare landscape through its algorithm hub, interdisciplinary approach, and real-world evidence expertise. The company's impactful strides in maternal and infant health, children's health, mental health, substance use disorder, eye health, infectious diseases, and pathology lay the foundation for accelerating our mission to build healthier communities.